Mark P. Lythgoe
Impact in
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 24
- Cancer Immunotherapy and Biomarkers 9
- Colorectal Cancer Treatments and Studies 5
-
- Health Systems, Economic Evaluations, Quality of Life 14
- Economic and Financial Impacts of Cancer 13
- Pharmaceutical Economics and Policy 5
- Co-authors
- Paul Middleton (3 shared papers)Vinay Prasad (9 shared papers)Jonathan Krell (22 shared papers)David J. Benjamin (12 shared papers)D. J. Lewis (1 shared paper)Adam E. Frampton (6 shared papers)Philip Savage (6 shared papers)Maximilian Julve (5 shared papers)
- Journals
- The Lancet Oncology (8 papers)Annals of Oncology (6 papers)Journal of Clinical Oncology (6 papers)JAMA Network Open (4 papers)Cancers (3 papers)
- Partner nations
- United KingdomUnited StatesCanada
In The Last Decade
Mark P. Lythgoe
60 papers receiving 941 citations
Peers
Comparison fields: 5 of 110
- Infectious Diseases 228
- Oncology 203
- Immunology 113
- Neurology 56
- Biological Psychiatry 9
Countries citing papers authored by Mark P. Lythgoe
This map shows the geographic impact of Mark P. Lythgoe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark P. Lythgoe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark P. Lythgoe more than expected).
Fields of papers citing papers by Mark P. Lythgoe
This network shows the impact of papers produced by Mark P. Lythgoe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark P. Lythgoe. The network helps show where Mark P. Lythgoe may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark P. Lythgoe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 70 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 276 | |
| 2 | 2022 | 51 | |
| 3 | 2020 | 40 | |
| 4 | 2015 | 37 | |
| 5 | 2022 | 37 | |
| 6 | 2017 | 33 | |
| 7 | 2016 | 32 | |
| 8 | 2021 | 31 | |
| 9 | 2023 | 30 | |
| 10 | 2022 | 30 | |
| 11 | 2024 | 29 | |
| 12 | 2021 | 28 | |
| 13 | 2021 | 27 | |
| 14 | 2021 | 26 | |
| 15 | 2022 | 23 | |
| 16 | 2023 | 13 | |
| 17 | 2021 | 13 | |
| 18 | 2022 | 13 | |
| 19 | 2021 | 12 | |
| 20 | 2020 | 12 |
About Mark P. Lythgoe
Mark P. Lythgoe is a scholar working on Oncology, Economics and Econometrics, Molecular Biology, Pulmonary and Respiratory Medicine and Immunology, having authored 70 papers that have together received 961 indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (14 papers), Economic and Financial Impacts of Cancer (13 papers), Cancer Immunotherapy and Biomarkers (9 papers), Lung Cancer Treatments and Mutations (6 papers), Pharmaceutical Economics and Policy (5 papers), Colorectal Cancer Treatments and Studies (5 papers), Cancer Genomics and Diagnostics (5 papers) and Gut microbiota and health (3 papers). The work is most often cited by research in Infectious Diseases (228 citations), Oncology (203 citations), Immunology (113 citations), Neurology (56 citations) and Biological Psychiatry (9 citations). Mark P. Lythgoe has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include Paul Middleton, Vinay Prasad, Jonathan Krell, David J. Benjamin, D. J. Lewis, Adam E. Frampton, Philip Savage, Maximilian Julve, Jeremy L. Warner and Aakash Desai. Their work appears in journals such as The Lancet Oncology, Annals of Oncology, Journal of Clinical Oncology, JAMA Network Open and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.